CAS No.:521-35-7

TOXICITY DATA with REFERENCE：

1.		dni-hmn:hla 10 µmol/L		ANTRD4    Anticancer Research. 3 (1983),211.
2.		mnt-mus-ipr 50 mg/kg/5D-I		PHMGBN    Pharmacology: International Journal of Experimental and Clinical Pharmacology. 21 (1980),277.
3.		dni-mus-ipr 200 mg/kg		RCOCB8    Research Communications in Chemical Pathology and Pharmacology. 17 (1977),703.
4.		dni-mus:lng 2300 nmol/L		CNREA8    Cancer Research. 36 (1976),95.
5.		cyt-mus-ipr 50 mg/kg/5D-I		PHMGBN    Pharmacology: International Journal of Experimental and Clinical Pharmacology. 21 (1980),277.
6.		spm-mus-ipr 50 mg/kg/5D-C		PHMGBN    Pharmacology: International Journal of Experimental and Clinical Pharmacology. 18 (1979),143.
7.		orl-mus LD50:13,500 mg/kg		JPETAB    Journal of Pharmacology and Experimental Therapeutics. 88 (1946),154.

Consensus Reports：

EPA Genetic Toxicology Program.

SAFETY PROFILE：

Safety Information of Cannabinol (CAS NO. 521-35-7):
Hazard Codes: F ,T 
Risk Statements: 11-23/24/25-39
R11:Highly flammable
R23/24/25:Toxic by inhalation, in contact with skin and if swallowed
R39:Danger of very serious irreversible effects
Safety Statements: 7-16-36/37-45
S7:Keep container tightly closed
S16:Keep away from sources of ignition
S36/37:Wear suitable protective clothing and gloves
S45:In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
RIDADR: UN 1230 3/PG 2
WGK Germany: 1
RTECS: HP8575000
Low toxicity by ingestion. An experimental teratogen. Other experimental reproductive effects. Human mutation data reported. When heated to decomposition it emits acrid smoke and fumes. See also CANNABIS.

Standards and Recommendations：

 

Analytical Methods：